While not yet FDA-approved as a standalone agent, cagrilintide peptide therapy is being investigated for: Obesity treatment Metabolic syndrome management Adjunctive therapy for GLP-1 agonist non-responders Research in combination with emerging agents like retatrutide Note: As of 2025, cagrilintide is still considered a research compound in many jurisdictions
Why Joint Aches Occur with B12 Supplementation When joint discomfort does arise in temporal association with vitamin B12 therapy, several possible explanations may be considered, though none represent a direct toxic or pharmacological effect of cobalamin itself
Findings suggested possible normalization of immune cell responses to lipoproteins and reduction in plaque formation, leading researchers to consider a role in modulating inflammatory aspects of vascular function
11 involved patients with hyperuricaemia or gout, one included those with normal serum urate, and the rest did not distinguish baseline serum urate status
I joined a membership program guided by Cree, who walked me through every step and made me feel instantly at home
This assembly occurs in Cajal bodies nuclear structures that serve as assembly sites for ribonucleoprotein complexes before the holoenzyme is trafficked to telomeres
